Page 2 - Immunotherapy Program News Today

A new study from a team of University of Pittsburgh researchers offers further evidence about the importance of good gut health.

/PRNewswire/ -- Tampa General Hospital is announcing its appointment of Dr. Ivan Borrello to the TGH Cancer Institute. Borrello is a world-class translational...

Scientists believe that giving patients a fiber-rich diet of fruits, vegetables, beans, nuts and whole grains to nourish the gut microbiome might improve the odds that the cancer treatment immunotherapy is effective.

Cancer researchers think they have found one explanation for why some cancer drugs dont always work.

Adding messenger RNA, or mRNA therapy improves the response to cancer immunotherapy in patients who weren’t responding to the treatment, Mayo Clinic

Buffalo, N.Y. (PRWEB) November 04, 2021 -- Stress can have a significant negative effect on health, but our understanding of how stress impacts the

Personalized Cancer Vaccine Guided by Mount Sinai Computations Is Safe, Shows Potential Benefit Against Multiple Tumor Types Share Article A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual Americ...

 E-Mail New York, NY (April 10, 2021) - A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15. "While immunother...

Fecal transplant overcomes resistance to immunotherapy in melanoma patients Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut microbiome can transform patients with advanced melanoma who never responded to immunotherapy-;which has a failure rate of 40% for this type of cancer-;into patients who do. The results of this proof-of-principle phase II clinical trial were published online today in Science. In this study, a team of rese...

Fecal Microbiome Transplant Converts Melanoma Immunotherapy Non-Responders into Responders February 5, 2021 Scientists at the NIH in collaboration with UPMC Hillman Cancer Center have shown how some patients with advanced melanoma that hasn’t responded to immune checkpoint inhibitor therapy, can be converted to immunotherapy responders by giving them a fecal microbiota transplant (FMT), taken from patients who had responded very well to immunotherapy. Results from the proof-of-principle Phase...